Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting

Transplant Proc. 1999 Nov;31(7):2787-8. doi: 10.1016/s0041-1345(99)00567-9.

Authors

Y Kita¹, X K Li, N Funeshima, S Enosawa, A Tamura, S Hayashi, K Suzuki, T Kazui, H Amemiya, S Suzuki

Affiliation

¹ Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.

PMID: 10578291
DOI: 10.1016/s0041-1345(99)00567-9

No abstract available

MeSH terms

Abatacept
Animals
Antigens, CD
Antigens, Differentiation / genetics
Antigens, Differentiation / therapeutic use*
CTLA-4 Antigen
Combined Modality Therapy
Fingolimod Hydrochloride
Genetic Therapy
Graft Survival*
Heart Transplantation / immunology*
Humans
Immunoconjugates*
Immunosuppressive Agents / therapeutic use*
Male
Propylene Glycols / therapeutic use*
Rats
Rats, Inbred Lew
Rats, Inbred Strains
Recombinant Fusion Proteins / therapeutic use
Sphingosine / analogs & derivatives
Transfection
Transplantation, Homologous

Substances

Antigens, CD
Antigens, Differentiation
CTLA-4 Antigen
CTLA4 protein, human
Ctla4 protein, rat
Immunoconjugates
Immunosuppressive Agents
Propylene Glycols
Recombinant Fusion Proteins
Abatacept
Fingolimod Hydrochloride
Sphingosine